60 related articles for article (PubMed ID: 18290375)
1. [Morphological and immunohistochemical characteristics in endometrial hyperplasia].
Kogan EA; Stanoevich IV; Kudrina EA; Ishchenko AI
Arkh Patol; 2007; 69(6):21-4. PubMed ID: 18290375
[TBL] [Abstract][Full Text] [Related]
2. Calretinin: an immunohistochemical marker for the normal functional endometrial stroma and alterations of the immunoreactivity in dysfunctional uterine bleeding.
Al Moghrabi H; Elkeilani A; Thomas JM; Mai KT
Pathol Res Pract; 2007; 203(2):79-83. PubMed ID: 17188434
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of the adult stem cell marker Musashi-1 in endometriosis and endometrial carcinoma.
Götte M; Wolf M; Staebler A; Buchweitz O; Kelsch R; Schüring AN; Kiesel L
J Pathol; 2008 Jul; 215(3):317-29. PubMed ID: 18473332
[TBL] [Abstract][Full Text] [Related]
4. [Clinical and morphological parallels and molecular aspects of the morphogenesis of adenomyosis].
Kogan EA; Unanian AL; Demura TA; Grechukhina OM; Sidorova IS; Kiselev VI
Arkh Patol; 2008; 70(5):8-12. PubMed ID: 19137775
[TBL] [Abstract][Full Text] [Related]
5. Endometrial eosinophilic syncytial change related to breakdown: immunohistochemical evidence suggests a regressive process.
Shah SS; Mazur MT
Int J Gynecol Pathol; 2008 Oct; 27(4):534-8. PubMed ID: 18753967
[TBL] [Abstract][Full Text] [Related]
6. Cytological criteria of endometrial lesions with emphasis on stromal and epithelial cell clusters: result of 8 years of experience with intrauterine sampling.
Kobayashi H; Otsuki Y; Simizu S; Yamada M; Mukai R; Sawaki Y; Nakayama S; Torii Y
Cytopathology; 2008 Feb; 19(1):19-27. PubMed ID: 17916089
[TBL] [Abstract][Full Text] [Related]
7. Stromal luteoma and nodular hyperthecosis of the bilateral ovaries associated with atypical endometrial hyperplasia of the uterus.
Yamada S; Tanimoto A; Wang KY; Shimajiri S; Sasaguri Y
Pathol Int; 2009 Nov; 59(11):831-3. PubMed ID: 19883437
[No Abstract] [Full Text] [Related]
8. A typical stromal cells in a hyperplastic endometrial polyp.
Pitt MA; Roberts IS
Histopathology; 1996 Jul; 29(1):95. PubMed ID: 8818704
[No Abstract] [Full Text] [Related]
9. Ultrastructural cell-to-cell interactions in hyperplastic endometrial stroma.
Horbelt DV; Roberts DK; Parmley TH; Walker NJ
Gynecol Oncol; 1994 Dec; 55(3 Pt 1):433-42. PubMed ID: 7835784
[TBL] [Abstract][Full Text] [Related]
10. Glandular and stromal area in hyperplastic endometrium and carcinoma.
Dey P; Rajesh L
Anal Quant Cytol Histol; 2004 Aug; 26(4):239-40. PubMed ID: 15457678
[No Abstract] [Full Text] [Related]
11. [The proapoptotic factor HLDF in the normal, hyperplastic and neoplastic endometrium].
Koviazin VA; Shchelokova EE; Kostanian IA; Dranitsyna SM; Frolova II; Babichenko II
Arkh Patol; 2007; 69(3):23-6. PubMed ID: 17722590
[TBL] [Abstract][Full Text] [Related]
12. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
Witkiewicz AK; McConnell T; Potoczek M; Emmons RV; Kurman RJ
Hum Pathol; 2010 Jan; 41(1):26-32. PubMed ID: 19733383
[TBL] [Abstract][Full Text] [Related]
13. Morphologic changes in the endometrium associated with the use of the mirena coil: a retrospective study of 106 cases.
Hejmadi RK; Chaudhri S; Ganesan R; Rollason TP
Int J Surg Pathol; 2007 Apr; 15(2):148-54. PubMed ID: 17478768
[TBL] [Abstract][Full Text] [Related]
14. BAG-1 expression in normal endometrium, endometrial hyperplasia and endometrial cancer.
Song JY; Kim JW; Lee JK; Lee NW; Yeom BW; Kim SH; Lee KW
Acta Obstet Gynecol Scand; 2008; 87(8):862-7. PubMed ID: 18704778
[TBL] [Abstract][Full Text] [Related]
15. Multifocal PEComa (PEComatosis) of the female genital tract associated with endometriosis, diffuse adenomyosis, and endometrial atypical hyperplasia.
Froio E; Piana S; Cavazza A; Valli R; Abrate M; Gardini G
Int J Surg Pathol; 2008 Oct; 16(4):443-6. PubMed ID: 18499690
[TBL] [Abstract][Full Text] [Related]
16. Ureteral endometriosis: clinicopathological and immunohistochemical study of 7 cases.
Al-Khawaja M; Tan PH; MacLennan GT; Lopez-Beltran A; Montironi R; Cheng L
Hum Pathol; 2008 Jun; 39(6):954-9. PubMed ID: 18538172
[TBL] [Abstract][Full Text] [Related]
17. New histopathological experimental model for benign prostatic hyperplasia: stromal hyperplasia in rats.
Mori F; Oda N; Sakuragi M; Sakakibara F; Kiniwa M; Miyoshi K
J Urol; 2009 Feb; 181(2):890-8. PubMed ID: 19095262
[TBL] [Abstract][Full Text] [Related]
18. [Pathohistological changes characteristic for endometrial hyperplasia].
Putkaradze MSh; Chomakhashvili ZD
Georgian Med News; 2005 Jun; (123):43-5. PubMed ID: 16052055
[TBL] [Abstract][Full Text] [Related]
19. Expression of cyclin D1 in endometrial hyperplasia and endometrial carcinoma.
Choudhury M; Bansal S
Indian J Pathol Microbiol; 2007 Oct; 50(4):708-10. PubMed ID: 18306533
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of nuclear receptor corepressor (NCoR) in progestin-induced growth suppression of endometrial hyperplasia and carcinoma.
Kashima H; Horiuchi A; Uchikawa J; Miyamoto T; Suzuki A; Ashida T; Konishi I; Shiozawa T
Anticancer Res; 2009 Apr; 29(4):1023-9. PubMed ID: 19414341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
